Movatterモバイル変換

[0]ホーム
URL:

EA202092278A1 - RIMEGEPANT FOR CGRP-RELATED DISORDERS - Google Patents

RIMEGEPANT FOR CGRP-RELATED DISORDERS

Info

Publication number
EA202092278A1
EA202092278A1EA202092278AEA202092278AEA202092278A1EA 202092278 A1EA202092278 A1EA 202092278A1EA 202092278 AEA202092278 AEA 202092278AEA 202092278 AEA202092278 AEA 202092278AEA 202092278 A1EA202092278 A1EA 202092278A1
Authority
EA
Eurasian Patent Office
Prior art keywords
related disorders
cgrp
rimegepant
remegepant
disclosed
Prior art date
Application number
EA202092278A
Other languages
Russian (ru)
Inventor
Владимир Корик
Роберт Крооп
Original Assignee
Биохэвен Фармасьютикэл Холдинг Компани Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Биохэвен Фармасьютикэл Холдинг Компани Лтд.filedCriticalБиохэвен Фармасьютикэл Холдинг Компани Лтд.
Priority claimed from PCT/US2019/023940external-prioritypatent/WO2019191008A1/en
Publication of EA202092278A1publicationCriticalpatent/EA202092278A1/en

Links

Landscapes

Abstract

Translated fromRussian

Раскрыты способы лечения связанных с CGRP расстройств, например мигрени, посредством введения пациенту, нуждающемуся в этом, римегепанта или его фармацевтически приемлемой соли. Также раскрыты фармацевтические композиции, содержащие римегепант, и наборы, включающие в себя фармацевтические композиции и инструкции.Methods are disclosed for treating CGRP-related disorders such as migraine by administering to a patient in need thereof a remegepant or a pharmaceutically acceptable salt thereof. Also disclosed are pharmaceutical compositions containing remegepant and kits including pharmaceutical compositions and instructions.

EA202092278A2018-12-102019-03-25 RIMEGEPANT FOR CGRP-RELATED DISORDERSEA202092278A1 (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
US201862777625P2018-12-102018-12-10
PCT/US2019/023940WO2019191008A1 (en)2018-03-252019-03-25Rimegepant for cgrp related disorders

Publications (1)

Publication NumberPublication Date
EA202092278A1true EA202092278A1 (en)2021-03-17

Family

ID=75262237

Family Applications (1)

Application NumberTitlePriority DateFiling Date
EA202092278AEA202092278A1 (en)2018-12-102019-03-25 RIMEGEPANT FOR CGRP-RELATED DISORDERS

Country Status (1)

CountryLink
EA (1)EA202092278A1 (en)

Similar Documents

PublicationPublication DateTitle
ZA202204929B (en)Rimegepant for cgrp related disorders
EA201992878A1 (en) COMPOUNDS FOR TREATMENT OF HUNTINGTON'S DISEASE
SA518392101B1 (en)Benzimidazole Derivatives as Modulators of ROR-GAMMA
EA201991399A1 (en) AMINOTRIAZOLOPYRIDINE COMPOUNDS AND THEIR APPLICATION IN TREATMENT OF CANCER
EA202092490A1 (en) METHYL-MODIFYING ENZYMES MODULATORS, COMPOSITIONS AND THEIR APPLICATION
EA201891191A1 (en) 2-SUBSTITUTED HINAZOLIN COMPOUNDS CONTAINING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF THEIR APPLICATION
EA201891203A1 (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
MX385332B (en) ROR-GAMMA MODULATORS.
EA201691516A1 (en) DIHYDROPYRROLOPIRIDINOVYY INHIBITORS ROR-GAMMA
EA201691803A1 (en) HUMAN PLASMA KALLIKREIN INHIBITORS
EA201592250A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseases
EA201790528A1 (en) DIHYDROPYRROLOPIRIDINOVYY INHIBITORS ROR-GAMMA
EA201892075A1 (en) COMBINATION OF LSD1 INHIBITORS FOR USE FOR THE TREATMENT OF SOLID TUMORS
MX386782B (en) INDOLINE DERIVATIVES SUBSTITUTED AS INHIBITORS OF DENGUE VIRAL REPLICATION.
EA201892216A1 (en) SUBSTITUTED INDIN DERIVATIVES AS AN INHIBITORS OF DENG VIRUS REPLICATION
EA201992334A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA201992782A1 (en) SUBSTITUTED INDOLINE DERIVATIVES AS MONEY VIRUS REPLICATION INHIBITORS
EA202192905A1 (en) COMPOUNDS CONTAINING N-METHYL-2-PYRIDONE AND PHARMACEUTICALLY ACCEPTABLE SALTS
EA201692481A1 (en) COMBINATION CONTAINING GLUCOCORTICOID AND EDO-S101
EA201791829A1 (en) AMIDE CONNECTIONS AS AGENTISTS OF 5-HT RECEPTOR
EA202091112A1 (en) SOCRYSTALS, PHARMACEUTICAL COMPOSITIONS BASED ON THEIR BASED AND METHODS OF TREATMENT FOR THEIR APPLICATION
EA201790253A1 (en) ALDOSTERONSYNTASE INHIBITORS
MX2021011081A (en) NICORANDIL DERIVATIVES.
JOP20200242A1 (en) Palladiumide compounds and their uses
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
[8]ページ先頭
©2009-2025 Movatter.jp